Stockscreener 앱 받기
2.03
11.21%
-0.29
시간 외 거래:
2.05
0.02
+0.99%
전일 마감가:
$2.32
열려 있는:
$2.11
하루 거래량:
17,160
Relative Volume:
0.67
시가총액:
$16.60M
수익:
-
순이익/손실:
-
주가수익비율:
-2.5167
EPS:
-0.8066
순현금흐름:
-
1주 성능:
-10.43%
1개월 성능:
+11.35%
6개월 성능:
-21.07%
1년 성능:
-35.83%
1일 변동 폭
$1.99
$2.30
1주일 범위
$1.99
$2.40
52주 변동 폭
$1.33
$3.78
Neuraxis Inc Stock (NRXS) Company Profile
명칭
Neuraxis Inc
전화
(812) 689-0791
주소
11550 North Meridian Street, Suite 325, Carmel
NRXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
2.06 | 16.60M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.85 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.88 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.56 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.84 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.54 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuraxis Inc 주식(NRXS)의 최신 뉴스
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025 - The Manila Times
The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis - Yahoo Finance
Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems - Yahoo Finance
Small Cap Med-Tech Names Are More Insulated from Tariff Fallout - The Wall Street Transcript
Interview with the CEO: Abivax SA (NASDAQ:ABVX) - The Wall Street Transcript
Onshoring Drug Manufacturing Is Critical, But Not Easy - The Wall Street Transcript
Enphase Energy, Inc. (NASDAQ:ENPH) Given Average Rating of “Hold” by Analysts - Defense World
NeurAxis, Inc. (NASDAQ:NRXS) Stake Reduced by Bank of Montreal Can - Defense World
NeurAxis (NASDAQ:NRXS) Stock Price Up 10.3% – Still a Buy? - Defense World
NRXS stock touches 52-week low at $1.38 amid market challenges By Investing.com - Investing.com South Africa
NRXS stock touches 52-week low at $1.38 amid market challenges - Investing.com India
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS - GlobeNewswire
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on - Bluefield Daily Telegraph
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 - Yahoo Finance
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
Critical Analysis: CeriBell (NASDAQ:CBLL) versus NeurAxis (NASDAQ:NRXS) - Defense World
Neuraxis stock hits 52-week low at $1.98 amid market challenges By Investing.com - Investing.com South Africa
Neuraxis stock hits 52-week low at $1.98 amid market challenges - Investing.com India
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2024 Earnings Call Transcript - MSN
NeurAxis (NASDAQ:NRXS) Trading Down 0.9% – Should You Sell? - Defense World
NeurAxis Stock Gains Post Q4 Earnings And Revenue Growth - Barchart
NeurAxis Stock Gains Post Q4 Earnings and Revenue Growth - Zacks Investment Research
NeurAxis (NASDAQ:NRXS) & BioLife Solutions (NASDAQ:BLFS) Head-To-Head Analysis - Defense World
NeurAxis, Inc. Reports Strong Q4 Growth Amid Challenges - TipRanks
NeurAxis revenues increase 43% to USD 761K in Q4 2024 - Medical Buyer
NeurAxis, Inc. Reports Strong Q4 2024 Results - TipRanks
Earnings call transcript: Neuraxis Q4 2024 sees revenue growth, loss narrows - Investing.com Canada
Earnings call transcript: Neuraxis Q4 2024 sees revenue growth, loss narrows By Investing.com - Investing.com South Africa
NeurAxis Better on Q4 Results - Baystreet.ca
NeurAxis, Inc. Reports 43% Revenue Growth in Q4 2024 and Significant Milestones Achieved - Nasdaq
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues - GlobeNewswire
Earnings Scheduled For March 20, 2025 - Benzinga
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025 - The Manila Times
NeurAxis, Inc. Set to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 20, 2025 - Nasdaq
NRXS stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa
NRXS stock touches 52-week low at $1.99 amid market challenges - Investing.com
Vagus Nerve Stimulators Market Detailed In New Research Report - openPR
NeurAxis (NASDAQ:NRXS) Stock Price Down 2.8% – Here’s Why - Defense World
Chronic Idiopathic Constipation Clinical Trials and Pipeline - openPR
Interview with the Chairman and CEO: The Real Brokerage Inc. (NASDAQ:REAX) - The Wall Street Transcript
Critical Contrast: NeurAxis (NASDAQ:NRXS) & Zynex (NASDAQ:ZYXI) - Defense World
Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR
Analyzing NeurAxis (NASDAQ:NRXS) and Masimo (NASDAQ:MASI) - Defense World
End Of January 2025 Portfolio Review - substack.com
FDA Clears NeurAxis’ Self-Inflating Balloon Device - MPO-mag
Neuraxis Inc (NRXS) 재무 분석
Neuraxis Inc (NRXS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.52%
0.52%
자본화:
|
볼륨(24시간):